HTDI 2022

Event Details

  • Start Date 12/15/2022
  • Start Time 08:30
  • End Time 00:00
Topics Speakers Time Venue
SUPERFICIAL VENOUS DISEASE I 13.45-14.39 Session 20
Human lymphatic glycocalyx identification 13.46
The modern phlebology: from aesthetic to advanced disease. How to do it? 13.52
Why the CHIVA procedure is not performed by most surgeons, despite the high scientific evidence of cost-efficacy 13.58
Lesson learned from a multicenter study on endothermal ablation 14.04
Saphenous vein ablation with cyanoacrylate glue: the Italian registry 14.10
One fit most technique: laser can treat all refluxes and recurrencies 14.16
Ablation of perforating veins: when and how? 14.22
Round table/Discussion 14.28-14.39
KEYNOTE LECTURE IX 14.40-14.54
SUPERFICIAL VENOUS DISEASE II 14.55-15.49 Session 21
Venous thromboembolic risk assessment for endovenous and foam interventions 14.56
Sclerotherapy with “superfoam”: preliminary results 15.02
Long term results of MOCA for saphenous vein incompetency 15.08
Ballon Catheter Sclerotherapy in empty vein 15.14
MOCA and crossectomy in saphenous vein insufficiency 15.20
High intensity focused ultrasound (HIFU) for the treatment of truncal reflux: a potentially disruptive technology 15.26
Do we need compression after superficial ablation? 15.32
Round table/Discussion 15.38-15.49
DEEP VEIN THROMBOSIS 15.50-16.38 Session 22
Antithrombotic therapy after venous stenting: do we need RCTs? 15.51
New devices for acute deep vein thrombosis 15.57
When conservative treatment is not the best choice for Acute DVT treatment 16.03
Mechanical thrombectomy may reduce intraprocedural complications 16.09
Endovascular treatment of Deep Vein Thrombosis: the new intelligent clot removal concept 16.15
Risk factors and classification of reintervention following deep venous stenting for acute iliofemoral deep vein thrombosis 16.21
Round table/Discussion 16.27-16.38
KEYNOTE LECTURE X 16.39-16.49
COMPRESSIVE DISEASE AND PELVIC CONGESTION SYNDROME 16.50-17.44 Session 23
How to assess illusory May-Thurner syndrome by ultrasound 16.51
Endovascular treatment of central venous obstructive disease 16.57
IVUS guidance for diagnosis and stenting of MTS 17.03
Incidence, outcome, and management of venous stent migration 17.09
Venous obstruction in PCS needs to be treated first 17.15
Pelvic vein embolization as first choice in PCS with obstruction 17.21
Pelvic Congestion Syndrome: the Italian consensus 17.27
Round table/Discussion 17.33-17.44
POST-THROMBOTIC SYNDROME 17.45-18.20 Session 24
Misconceptions regarding elastic compression for prevention of post-thrombotic changes 17.46
Deep valve reconstruction after outflow recanalization 17.52
How to improve inflow (Access PTS) 17.58
Neointima formation following venous stenting: clinical and experimental results 18.04
Complex IVC reconstruction with different stent configuration 18.10
Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein 18.16
Current evidence on deep venous recanalization following recent trials 18.22
Performance of open and closed cell laser cut nitinol stents for the treatment of chronic iliofemoral venous outflow obstruction 18.28
Round table/Discussion 18.34-18.44